Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, acts as a highly effective HIV medication. It blocks the multiplication of the human immunodeficiency virus (HIV) by stopping the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, facilitating the virus to integrate its genetic material into the host's D

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor employed in the management of human immunodeficiency virus disease. Its therapeutic properties stem from the selective inhibition of reverse transcriptase, an enzyme crucial for HIV replication. Abacavir sulfate is a derivative that transits modification to its active form, ca

read more

Top-Tier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for businesses of all sizes. The premier global API manufacturer and supplier provides a comprehensive selection of cutting-edge APIs designed to meet the diverse needs of modern applications. With a proven commitment to quality, innovation, and cu

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleotide reverse transcriptase inhibitor. Its mechanism of action involves the competitive suppression of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its action by being incorporated into the growing DNA chain during reverse transcription, leading to premature halt. This ulti

read more

A Top Nutraceutical API Producer

India has firmly established itself as a global hub for dietary supplement ingredient production, particularly in the realm of Active Pharmaceutical Ingredients (compounds). Numerous domestic firms specialize in the contract fabrication of natural health active ingredients, serving both the domestic market and exporting globally. These firms boast

read more